187 related articles for article (PubMed ID: 33977308)
21. Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.
Tachibana T; Kasajima A; Aoki T; Tabata T; McNamara K; Yazdani S; Satoko S; Fujishima F; Motoi F; Unno M; Sasano H
J Steroid Biochem Mol Biol; 2020 Jul; 201():105694. PubMed ID: 32437964
[TBL] [Abstract][Full Text] [Related]
22. Serotonin-positive neuroendocrine neoplasm with pancreatic ductal dilation in which cytological immunostaining contributed to the diagnosis.
Ariga H; Kashimura J; Horigome Y; Okada K
Clin J Gastroenterol; 2022 Aug; 15(4):822-825. PubMed ID: 35471694
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.
Guo C; Chen X; Xiao W; Wang Q; Sun K; Wang Z
Onco Targets Ther; 2017; 10():1465-1474. PubMed ID: 28331340
[TBL] [Abstract][Full Text] [Related]
24. Rb Loss and
Hijioka S; Hosoda W; Matsuo K; Ueno M; Furukawa M; Yoshitomi H; Kobayashi N; Ikeda M; Ito T; Nakamori S; Ishii H; Kodama Y; Morizane C; Okusaka T; Yanagimoto H; Notohara K; Taguchi H; Kitano M; Yane K; Maguchi H; Tsuchiya Y; Komoto I; Tanaka H; Tsuji A; Hashigo S; Kawaguchi Y; Mine T; Kanno A; Murohisa G; Miyabe K; Takagi T; Matayoshi N; Yoshida T; Hara K; Imamura M; Furuse J; Yatabe Y; Mizuno N
Clin Cancer Res; 2017 Aug; 23(16):4625-4632. PubMed ID: 28455360
[No Abstract] [Full Text] [Related]
25. Small serotonin-positive pancreatic endocrine tumors caused obstruction of the main pancreatic duct.
Ogawa M; Kawaguchi Y; Maruno A; Ito H; Nakagohri T; Hirabayashi K; Yamamuro H; Yamashita T; Mine T
World J Gastroenterol; 2012 Dec; 18(45):6669-73. PubMed ID: 23236243
[TBL] [Abstract][Full Text] [Related]
26. Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years.
Fujimori N; Miki M; Lee L; Matsumoto K; Takamatsu Y; Takaoka T; Teramatsu K; Suehiro Y; Murakami M; Igarashi H; Oono T; Ohtsuka T; Nakamura M; Koga Y; Oda Y; Ito T; Ogawa Y
Pancreatology; 2020 Jun; 20(4):709-715. PubMed ID: 32360001
[TBL] [Abstract][Full Text] [Related]
27. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
[TBL] [Abstract][Full Text] [Related]
28. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.
Kawamoto S; Shi C; Hruban RH; Choti MA; Schulick RD; Fishman EK; Siegelman SS
AJR Am J Roentgenol; 2011 Sep; 197(3):W482-8. PubMed ID: 21862776
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
[TBL] [Abstract][Full Text] [Related]
30. Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms.
Grolmusz VK; Kövesdi A; Borks K; Igaz P; Patócs A
Eur J Endocrinol; 2018 Oct; 179(4):219-228. PubMed ID: 30299890
[TBL] [Abstract][Full Text] [Related]
31. Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay.
De Robertis R; Paiella S; Cardobi N; Landoni L; Tinazzi Martini P; Ortolani S; De Marchi G; Gobbo S; Giardino A; Butturini G; Tortora G; Bassi C; D'Onofrio M
Abdom Radiol (NY); 2018 Mar; 43(3):613-619. PubMed ID: 28677005
[TBL] [Abstract][Full Text] [Related]
32. Clinical and radiologic characteristics of pancreatic head carcinoma without main pancreatic duct dilatation: using dual-phase contrast-enhanced CT scan.
Ko SE; Choi IY; Cha SH; Yeom SK; Lee SH; Chung HH; Hyun JJ
Clin Imaging; 2016; 40(3):548-52. PubMed ID: 27133702
[TBL] [Abstract][Full Text] [Related]
33. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database.
Yang Z; Shi G
Eur J Surg Oncol; 2022 Oct; 48(10):2181-2187. PubMed ID: 35623986
[TBL] [Abstract][Full Text] [Related]
34. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
35. Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation.
de Vries C; Konukiewitz B; Weichert W; Klöppel G; Aupperle-Lellbach H; Steiger K
J Comp Pathol; 2020 Nov; 181():73-85. PubMed ID: 33288156
[TBL] [Abstract][Full Text] [Related]
36. Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms.
Palmieri LJ; Dermine S; Barré A; Dhooge M; Brezault C; Cottereau AS; Coriat R
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32549203
[TBL] [Abstract][Full Text] [Related]
37. Association between pathologic grade and multiphase computed tomography enhancement in pancreatic neuroendocrine neoplasm.
Kang J; Ryu JK; Son JH; Lee JW; Choi JH; Lee SH; Kim YT
J Gastroenterol Hepatol; 2018 Mar; ():. PubMed ID: 29514405
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
39. Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms.
Crippa S; Pergolini I; Rubini C; Castelli P; Partelli S; Zardini C; Marchesini G; Zamboni G; Falconi M
Surgery; 2016 Apr; 159(4):1041-9. PubMed ID: 26704784
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
